270 related articles for article (PubMed ID: 26607153)
1. Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
Yu D; Ye X; Wu Q; Li S; Yang Y; He J; Liu Y; Zhang X; Yuan Q; Liu M; Li D; Ren G
Endocrine; 2016 Jun; 52(3):527-40. PubMed ID: 26607153
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
3. [The synergistic effect of FGF-21 and insulin on regulating glucose metabolism and its mechanism].
Yu D; Sun CY; Sun GP; Ren GP; Ye XL; Zhu SL; Wang WF; Xu PF; Li SJ; Wu Q; Niu ZS; Sun T; Liu MY; Li DS
Yao Xue Xue Bao; 2014 Jul; 49(7):977-84. PubMed ID: 25233627
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
5. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
Xu P; Ye X; Zhang Y; Yuan Q; Liu M; Wu Q; Ren G; Li D
J Diabetes Complications; 2015; 29(1):5-12. PubMed ID: 25456819
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling-dependent manner.
Pan Y; Wang B; Zheng J; Xiong R; Fan Z; Ye Y; Zhang S; Li Q; Gong F; Wu C; Lin Z; Li X; Pan X
J Cell Mol Med; 2019 Feb; 23(2):1059-1071. PubMed ID: 30461198
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
Li S; Wang N; Guo X; Li J; Zhang T; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():355-366. PubMed ID: 30227329
[TBL] [Abstract][Full Text] [Related]
8. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
[TBL] [Abstract][Full Text] [Related]
10. Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth.
Gu C; Zeng Y; Tang Z; Wang C; He Y; Feng X; Zhou L
Mol Med Rep; 2015 Nov; 12(5):6451-60. PubMed ID: 26323321
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
14. The caffeoylquinic acid-rich Pandanus tectorius fruit extract increases insulin sensitivity and regulates hepatic glucose and lipid metabolism in diabetic db/db mice.
Wu C; Zhang X; Zhang X; Luan H; Sun G; Sun X; Wang X; Guo P; Xu X
J Nutr Biochem; 2014 Apr; 25(4):412-9. PubMed ID: 24629909
[TBL] [Abstract][Full Text] [Related]
15. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance.
Liepinsh E; Makrecka-Kuka M; Makarova E; Volska K; Svalbe B; Sevostjanovs E; Grinberga S; Kuka J; Dambrova M
Pharmacol Res; 2016 Nov; 113(Pt B):788-795. PubMed ID: 26621248
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 improves insulin sensitivity and synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes.
Lee DV; Li D; Yan Q; Zhu Y; Goodwin B; Calle R; Brenner MB; Talukdar S
PLoS One; 2014; 9(11):e111767. PubMed ID: 25365322
[TBL] [Abstract][Full Text] [Related]
17. Eurocristatine, a plant alkaloid from Eurotium cristatum, alleviates insulin resistance in db/db diabetic mice via activation of PI3K/AKT signaling pathway.
Zhang H; Hui J; Yang J; Deng J; Fan D
Eur J Pharmacol; 2020 Nov; 887():173557. PubMed ID: 32946868
[TBL] [Abstract][Full Text] [Related]
18.
Seo YJ; Lee K; Chei S; Jeon YJ; Lee BY
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31323977
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice.
Ye X; Qi J; Wu Y; Yu D; Xu P; Li S; Zhu S; Wu Q; Ren G; Li D
Diabetes Metab; 2015 Feb; 41(1):82-90. PubMed ID: 25451186
[TBL] [Abstract][Full Text] [Related]
20. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]